ICD10 code of Acromegaly and ICD9 code

The ICD-10 code for acromegaly is E22.0, while the legacy ICD-9 code is 253.0. These classification codes are essential for medical billing, insurance authorization, and clinical documentation for patients managing this rare hormonal disorder.

What is the clinical definition of acromegaly?

Acromegaly is a rare, chronic endocrine disorder characterized by the overproduction of growth hormone (GH), usually caused by a benign tumor (adenoma) on the pituitary gland. When this excess GH secretion occurs in adulthood, it leads to the gradual enlargement of bones, soft tissues, and organs. Because the onset of acromegaly is often insidious, patients may live with symptoms for several years before receiving an accurate diagnosis. At DiseaseMaps.org, we currently support a community of 112 people who have shared their experiences living with the physical and emotional challenges of acromegaly.

How is acromegaly diagnosed and coded?

Diagnosis typically begins with an elevated serum Insulin-like Growth Factor-1 (IGF-1) level, followed by a GH suppression test using oral glucose. Once diagnosed, clinicians use the ICD-10 code E22.0 to formally record acromegaly in the electronic health record. Accurate coding is vital not only for insurance coverage of expensive medical therapies—such as somatostatin analogs or growth hormone receptor antagonists—but also for tracking the prevalence of acromegaly in global health databases. While the ICD-9 code 253.0 is no longer used for current billing, you may still see it referenced in older medical records or historical research literature.

What are the primary complications of acromegaly?

If left untreated, the systemic effects of acromegaly can significantly impact quality of life and long-term health outcomes. Clinical management focuses on normalizing GH and IGF-1 levels to mitigate the following common complications:

• Cardiovascular disease: Including hypertension, cardiomyopathy, and heart failure.


• Metabolic disturbances: Such as insulin resistance, impaired glucose tolerance, or type 2 diabetes mellitus.


• Skeletal and joint issues: Chronic arthropathy, carpal tunnel syndrome, and spinal stenosis.


• Sleep apnea: Obstructive sleep apnea is highly prevalent due to soft tissue hypertrophy in the airway.


• Neoplastic risk: An increased predisposition to colonic polyps, necessitating regular screening colonoscopies.

How does the diagnosis of acromegaly affect mental health?

Receiving a diagnosis of acromegaly is a life-altering event that often carries a heavy psychological burden. Changes in physical appearance—such as the enlargement of hands, feet, and facial features—can lead to body image distress, social anxiety, and feelings of isolation. Our clinical psychology experts emphasize that it is normal to experience grief or frustration when navigating the complexities of a chronic condition. Connecting with others who understand the unique journey of living with acromegaly can be a vital component of your support strategy.

Next steps

• Consult an endocrinologist: Ensure you are under the care of a pituitary specialist or a neuro-endocrinologist experienced in managing acromegaly.


• Verify your records: Check your medical statements to ensure the ICD-10 code E22.0 is correctly used to facilitate access to specialized treatments.


• Join the community: Engage with the 112 members at DiseaseMaps.org to share experiences and coping strategies.


• Monitor symptoms: Keep a symptom diary to help your clinical team track the effectiveness of your treatment plan.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Acromegaly (ORPHA:157850)


• NIH GARD: Acromegaly (Genetic and Rare Diseases Information Center)


• OMIM: Acromegaly (Entry #102200)


• Pituitary Society: Clinical practice guidelines for the management of acromegaly.